Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...
Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...
The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...
UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...
Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this ...
Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...
Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...
US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific ...
Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...
The US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination ...
Last week’s regulatory news saw the US Food and Drug Administration (FDA) accept Swiss biotech Pharmvaris’ new drug application (NDA) for deucrictibant for the treatment hereditary angioedema (HAE) ...
Anglo-Swedish pharma major AstraZeneca has licensed ex-China rights to TQC3721, an investigational inhaled PDE3/4 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results